Publication | Closed Access
A paradigm of difficult-to-treat rheumatoid arthritis: subtypes and early identification
22
Citations
0
References
2022
Year
Patients with D2TRA-other are indistinguishable from non-D2TRA patients at baseline, indicating the former cohort does not appear to have any predictive value during the early stages of b/tsDMARD treatment, unlike what occurs in patients with D2TRA-inefficacy.